Figure 4.
Mean differences (95% CIs) of maternal circulating IGFBP-3 concentrations (ng/ml) in late gestation (30+ weeks) comparing GDM vs. euglycemic (control) women in five studies (seven data lines). Positive values denote higher values in GDM patients; negative values denote higher values in control subjects.